Thyrocare Technologies informs about investor meet

03 Dec 2018 Evaluate

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Thyrocare Technologies has informed that Robert Harvey and Taizo Ishida, Portfolio Managers of Matthews Asia would be having a meeting with Anand Velumani, Director of the company’s wholly owned subsidiary, Nueclear Healthcare, and Aditya Shinde, Deputy General Manager- Finance at Hotel Trident, BKC by 09.00 AM on Wednesday, December 05, 2018. There could be last minute change in the names of Analysts or in the timings. It is also informed that no unpublished Price-Sensitive Information will be shared during the meetings.

The above information is a part of company’s filings submitted to BSE.

Thyrocare Tech. Share Price

957.45 -12.90 (-1.33%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 6932.35
Max Healthcare Inst 999.80
Narayana Hrudayalay 1271.85
Aster DM Healthcare 432.35
Global Health 1114.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.